Reaper; Philip Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Reaper; Philip Michael.The latest application filed is for "compounds useful as inhibitors of atr kinase and combination therapies thereof".
Company Profile
4.27.31
- Reaper; Philip Michael - Abingdon GB
- REAPER; Philip Michael - Richmond Surrey
- Reaper; Philip Michael - Shillingford N/A GB
- Reaper; Philip Michael - Cambridge GB
Patent Activity
| Patent | Date |
|---|---|
| Compounds Useful As Inhibitors Of Atr Kinase And Combination Therapies Thereof App 20220233521 - POLLARD; John Robert ; et al. | 2022-07-28 |
| Compounds useful as inhibitors of ATR kinase and combination therapies thereof Grant 11,110,086 - Pollard , et al. September 7, 2 | 2021-09-07 |
| Methods Of Cancer Treatment Using An Atr Inhibitor App 20210196751 - PENNEY; Marina S. ; et al. | 2021-07-01 |
| Substituted pyrazines as ATR kinase inhibitors Grant 10,961,232 - Charrier , et al. March 30, 2 | 2021-03-30 |
| Treating Cancer With Atr Inhibitors App 20200390761 - POLLARD; John Robert ; et al. | 2020-12-17 |
| Treating cancer with ATR inhibitors Grant 10,813,929 - Pollard , et al. October 27, 2 | 2020-10-27 |
| Compounds Useful As Inhibitors Of Atr Kinase And Combination Therapies Thereof App 20200222392 - Pollard; John Robert ; et al. | 2020-07-16 |
| Compounds useful as inhibitors of ATR kinase and combination therapies thereof Grant 10,478,430 - Pollard , et al. Nov | 2019-11-19 |
| Substituted pyrazin-2-amines as inhibitors of ATR kinase Grant 10,479,784 - Charrier , et al. Nov | 2019-11-19 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20190047995 - CHARRIER; Jean-Damien ; et al. | 2019-02-14 |
| Method For Treating Cancer Using A Combination Of Dna Damaging Agents And Atr Inhibitors App 20180303829 - POLLARD; John Robert ; et al. | 2018-10-25 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20180170922 - Charrier; Jean-Damien ; et al. | 2018-06-21 |
| Substituted pyrazines as ATR kinase inhibitors Grant 9,701,674 - Charrier , et al. July 11, 2 | 2017-07-11 |
| Compounds useful as inhibitors of ATR kinase Grant 9,630,956 - Charrier , et al. April 25, 2 | 2017-04-25 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160311809 - Charrier; Jean-Damien ; et al. | 2016-10-27 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160271129 - Charrier; Jean-Damien ; et al. | 2016-09-22 |
| Substituted pyrazin-2-amines as inhibitors of ATR kinase Grant 9,365,557 - Charrier , et al. June 14, 2 | 2016-06-14 |
| Compounds useful as inhibitors of ATR kinase Grant 9,334,244 - Charrier , et al. May 10, 2 | 2016-05-10 |
| Compounds Useful As Inhibitors Of Atr Kinase And Combination Therapies Thereof App 20160030424 - Pollard; John Robert ; et al. | 2016-02-04 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20160009723 - Charrier; Jean-Damien ; et al. | 2016-01-14 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20150239874 - Charrier; Jean-Damien ; et al. | 2015-08-27 |
| Compounds useful as inhibitors of ATR kinase Grant 9,096,584 - Charrier , et al. August 4, 2 | 2015-08-04 |
| Compounds useful as inhibitors of ATR kinase Grant 9,062,008 - Charrier , et al. June 23, 2 | 2015-06-23 |
| Compounds useful as inhibitors of ATR kinase Grant 8,969,356 - Charrier , et al. March 3, 2 | 2015-03-03 |
| Compounds useful as inhibitors of ATR kinase Grant 8,962,631 - Charrier , et al. February 24, 2 | 2015-02-24 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20150051187 - Charrier; Jean-Damien ; et al. | 2015-02-19 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20150031661 - Charrier; Jean-Damien ; et al. | 2015-01-29 |
| Treating Cancer With Atr Inhibitors App 20140356456 - Pollard; John Robert ; et al. | 2014-12-04 |
| Aminopyrazines as ATR kinase inhibitors Grant 8,877,759 - Charrier , et al. November 4, 2 | 2014-11-04 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20140288347 - Charrier; Jean-Damien ; et al. | 2014-09-25 |
| Pyrazin-2-amines useful as inhibitors of ATR kinase Grant 8,841,308 - Charrier , et al. September 23, 2 | 2014-09-23 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20140113005 - Charrier; Jean-Damien ; et al. | 2014-04-24 |
| Compounds Useful As Inhibitors Of Atr Kinaseand Combination Therapies Thereof App 20140044802 - Pollard; John Robert ; et al. | 2014-02-13 |
| Compounds useful as inhibitors of ATR kinase Grant 8,623,869 - Charrier , et al. January 7, 2 | 2014-01-07 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20130095193 - Charrier; Jean-Damien ; et al. | 2013-04-18 |
| Treating Cancer with ATR Inhibitors App 20130089626 - Pollard; John Robert ; et al. | 2013-04-11 |
| Compounds useful as inhibitors of ATR kinase Grant 8,410,112 - Charrier , et al. April 2, 2 | 2013-04-02 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120177748 - Charrier; Jean-Damien ; et al. | 2012-07-12 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120178756 - Charrier; Jean-Damien ; et al. | 2012-07-12 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120122884 - Charrier; Jean-Damien ; et al. | 2012-05-17 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120046295 - Charrier; Jean-Damien ; et al. | 2012-02-23 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120040020 - Charrier; Jean-Damien ; et al. | 2012-02-16 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120035407 - Charrier; Jean-Damien ; et al. | 2012-02-09 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20120027874 - Charrier; Jean-Damien ; et al. | 2012-02-02 |
| Compounds Useful As Inhibitors Of Atr Kinase App 20100222318 - Charrier; Jean Damien ; et al. | 2010-09-02 |
| Methods and means for the treatment of disorders associated with cellular senescence App 20070099186 - D'Adda Di Fagagna; Fabrizio ; et al. | 2007-05-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 